The Atlanta Braves are navigating a tricky situation with injuries plaguing their starting rotation. But the real curveball came when Jurickson Profar was hit with a suspension for PED use.
Profar, serving as the Braves' designated hitter, faces a 162-game suspension after testing positive for a performance-enhancing drug for the second time in a year. This makes him the sixth player since 2014 to receive such a suspension under MLB's stricter rules for repeat offenders. His $15 million salary will be forfeited, adding a financial twist to the Braves' dilemma.
While this situation opens up some financial room for Atlanta, they might hold off on immediate moves. The Braves could use this newfound flexibility to make a splash at the trade deadline.
With the payroll space available, they could target almost any player who becomes available. If no suitable options arise, staying under the luxury tax threshold would provide even more flexibility, especially after any potential lockout ends.
It might not be the flashy move fans crave, but it's a strategic silver lining in an otherwise tough scenario.
The Braves now face a decision regarding Profar’s future. There’s precedent for players returning after a 162-game suspension.
Take Alex Rodriguez, who came back to the Yankees and delivered 33 home runs post-suspension. Or Robinson Canó, who, after multiple suspensions, found himself with the Braves and Padres.
Profar’s path could mirror these cases if the Braves choose to retain him.
The decision lies with the Braves, who are known for their prudent financial strategies. Cutting Profar and absorbing the financial hit might not align with GM Alex Anthopoulos’s approach.
Despite his missteps, Profar might get another shot to prove his worth, much like Rodriguez and Canó did. The door isn’t completely closed on his career just yet.